The 2026 paper reports no trial results because it is a trial protocol, not a completed study. Published on 4 June 2026, it lays out the design and methods for testing oral probiotics plus topical secretome, with no efficacy findings. Secretome means the cell-free mix of molecules released by mesenchymal stem cells, including growth factors, cytokines, extracellular vesicles and conditioned medium. For adults with persistent acne, the paper matters as a plan for future evidence rather than proof that the combination works now.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What will the planned trial test?
- Why study probiotics and secretome for acne?
- What treatments already have strong support?
- What can you ask a dermatologist?
What will the planned trial test?
The protocol describes a double-blind, randomised controlled trial of oral probiotics plus topical secretome to improve acne outcomes and restore microbiome. According to BMJ, the paper covers rationale, eligibility, interventions and methods only in the protocol publication.
PubMed likewise indexes the 2026 paper as protocol e109586, focused on planned clinical and microbiome endpoints rather than completed treatment results, as shown in the PubMed record. Readers should therefore expect future outcome papers to report whether lesions improve and how skin bacteria change.
Why study probiotics and secretome for acne?
The rationale cites laboratory work showing that Lactobacillus strains can inhibit Cutibacterium acnes growth and modulate inflammation. That finding makes probiotics a proposed adjunct approach, not a standalone cure.
Secretome is studied as a possible skin-repair therapy because its mix includes signals involved in cell communication and repair. Acne remains relevant for adults because it affects 85% of adolescents and often begins or continues in adulthood, especially in women, with reports that up to 15% of adult women are affected.
What treatments already have strong support?
Current dermatology guidance strongly supports topical benzoyl peroxide, retinoids and antibiotics in fixed combinations. Severe acne may also be treated with oral doxycycline or isotretinoin, with only conditional support for other agents.
That contrast is practical. Proven options have defined roles in care, while probiotics plus secretome still need controlled results. A prior scoping review found oral and topical probiotics reduced lesions and inflammation in some studies, but effects varied by strain and person and were sometimes comparable to benzoyl peroxide or antibiotics.
What can you ask a dermatologist?
Bring the protocol to the visit and ask how it relates to your acne type, history and current regimen. Ask what benefit would look like for you, how it would be measured, and over what time frame.
The U.S. Food and Drug Administration states that cosmetics do not require premarket approval except color additives, so ask for evidence behind product claims in the FDA authority page. Rare side effects have occurred with probiotics in reviewed studies.
- Does any probiotic or secretome product have trial evidence for my kind of acne?
- What are the possible risks, side effects and interactions with proven therapy?
- Should I continue benzoyl peroxide, retinoid, antibiotic, doxycycline or isotretinoin if prescribed?
- How will we track lesions, irritation, scarring and microbiome changes?
You Might Also Like
- The 2026 Oral Probiotic and Topical Secretome Acne Trial Protocol: Questions Adults With Persistent Acne Can Ask a Dermatologist
- Probiotics for Acne in a 2026 Systematic Review and Meta-Analysis: Questions Adults With Persistent Acne Can Ask a Dermatologist
- Skin Microbiome Outcomes in the 2026 Probiotic Acne Review: Questions Adults With Persistent Acne Can Ask a Dermatologist